Core Viewpoint - The report from Cinda Securities highlights the increasing demands for environmental quality and low-carbon industrial development during the 14th Five-Year Plan, indicating that energy conservation, environmental protection, and resource recycling are expected to maintain high prosperity levels [1] Group 1: Market Performance - As of June 6, the environmental protection sector rose by 0.46%, underperforming the broader market; the water governance sector increased by 1.38%, while the waste incineration sector declined by 0.31% [2] - The air governance sector saw an increase of 1.01%, while the solid waste sanitation sector dropped by 6.55% [2] Group 2: Industry Dynamics - The Ministry of Ecology and Environment released the "2024 China Ecological Environment Status Bulletin," indicating continuous improvement in national ecological environment quality, with an increase in the proportion of days with good air quality and a decrease in heavy pollution days [2] - A joint implementation plan for ecological protection compensation mechanisms along major rivers was announced, aiming for a stable operation by 2027 and comprehensive coverage by 2035 [2] Group 3: Policy Developments - The National Development and Reform Commission and the National Energy Administration issued a notice promoting the development of green electricity direct connection, which supports the integration of renewable energy production and consumption [3] - This policy is expected to optimize grid allocation and facilitate collaboration between waste incineration power generation and data centers, with several environmental companies actively exploring this new model [3] Group 4: Recommended Companies - Key recommendations include: Huanlan Environment (600323.SH), Xingrong Environment (000598.SZ), and Hongcheng Environment (600461.SH) for their stable profitability and positive cash flow [1] - Companies to watch include: Wangneng Environment (002034.SZ), Junxin Co., Ltd. (301109.SZ), Wuhan Holdings (600168.SH), and others [1]

Quantitative Models and Construction Methods Model Name: IC Hedging Strategy - **Model Construction Idea**: The strategy is based on the analysis of basis convergence factors and optimization strategies as discussed in the Cinda Derivatives Research Report Series III[45] - **Model Construction Process**: - **Backtesting Period**: July 22, 2022, to June 6, 2025[46] - **Spot End**: Hold the total return index of the corresponding underlying index[46] - **Futures End**: Use 70% of the funds for the spot end and short the same nominal principal amount of CSI 500 index futures contracts, occupying the remaining 30% of the funds[46] - **Rebalancing Rules**: Continuously hold the quarterly/monthly contracts until the remaining days to maturity are less than 2 days, then close the position at the closing price of the day and short the next quarterly/monthly contract at the closing price of the day[46] - **Model Evaluation**: The strategy performed well with positive weekly returns due to the expansion of the basis discount[49] Model Name: IF Hedging Strategy - **Model Construction Idea**: Similar to the IC Hedging Strategy, based on basis convergence factors and optimization strategies[45] - **Model Construction Process**: - **Backtesting Period**: July 22, 2022, to June 6, 2025[50] - **Spot End**: Hold the total return index of the corresponding underlying index[50] - **Futures End**: Use 70% of the funds for the spot end and short the same nominal principal amount of CSI 300 index futures contracts, occupying the remaining 30% of the funds[50] - **Rebalancing Rules**: Continuously hold the quarterly/monthly contracts until the remaining days to maturity are less than 2 days, then close the position at the closing price of the day and short the next quarterly/monthly contract at the closing price of the day[50] - **Model Evaluation**: The strategy performed well with positive weekly returns due to the expansion of the basis discount[54] Model Name: IH Hedging Strategy - **Model Construction Idea**: Similar to the IC Hedging Strategy, based on basis convergence factors and optimization strategies[45] - **Model Construction Process**: - **Backtesting Period**: July 22, 2022, to June 6, 2025[55] - **Spot End**: Hold the total return index of the corresponding underlying index[55] - **Futures End**: Use 70% of the funds for the spot end and short the same nominal principal amount of SSE 50 index futures contracts, occupying the remaining 30% of the funds[55] - **Rebalancing Rules**: Continuously hold the quarterly/monthly contracts until the remaining days to maturity are less than 2 days, then close the position at the closing price of the day and short the next quarterly/monthly contract at the closing price of the day[55] - **Model Evaluation**: The strategy performed well with positive weekly returns due to the expansion of the basis discount[58] Model Name: IM Hedging Strategy - **Model Construction Idea**: Similar to the IC Hedging Strategy, based on basis convergence factors and optimization strategies[45] - **Model Construction Process**: - **Backtesting Period**: July 22, 2022, to June 6, 2025[59] - **Spot End**: Hold the total return index of the corresponding underlying index[59] - **Futures End**: Use 70% of the funds for the spot end and short the same nominal principal amount of CSI 1000 index futures contracts, occupying the remaining 30% of the funds[59] - **Rebalancing Rules**: Continuously hold the quarterly/monthly contracts until the remaining days to maturity are less than 2 days, then close the position at the closing price of the day and short the next quarterly/monthly contract at the closing price of the day[59] - **Model Evaluation**: The strategy performed well with positive weekly returns due to the expansion of the basis discount[60] Model Backtesting Results - **IC Hedging Strategy**: - Annualized Return: -2.65% (monthly continuous), -1.77% (quarterly continuous), -0.74% (minimum discount strategy)[49] - Volatility: 3.91% (monthly continuous), 4.81% (quarterly continuous), 4.73% (minimum discount strategy)[49] - Maximum Drawdown: -7.51% (monthly continuous), -8.34% (quarterly continuous), -7.97% (minimum discount strategy)[49] - Net Value: 0.9264 (monthly continuous), 0.9504 (quarterly continuous), 0.9792 (minimum discount strategy)[49] - Annual Turnover: 12 (monthly continuous), 4 (quarterly continuous), 17.55 (minimum discount strategy)[49] - 2025 YTD Return: -2.82% (monthly continuous), -0.36% (quarterly continuous), 0.04% (minimum discount strategy)[49] - **IF Hedging Strategy**: - Annualized Return: 0.63% (monthly continuous), 0.92% (quarterly continuous), 1.46% (minimum discount strategy)[54] - Volatility: 3.05% (monthly continuous), 3.40% (quarterly continuous), 3.19% (minimum discount strategy)[54] - Maximum Drawdown: -3.95% (monthly continuous), -4.03% (quarterly continuous), -4.06% (minimum discount strategy)[54] - Net Value: 1.0181 (monthly continuous), 1.0264 (quarterly continuous), 1.0421 (minimum discount strategy)[54] - Annual Turnover: 12 (monthly continuous), 4 (quarterly continuous), 15.10 (minimum discount strategy)[54] - 2025 YTD Return: -0.53% (monthly continuous), 0.65% (quarterly continuous), 0.85% (minimum discount strategy)[54] - **IH Hedging Strategy**: - Annualized Return: 1.17% (monthly continuous), 2.11% (quarterly continuous), 1.83% (minimum discount strategy)[58] - Volatility: 3.17% (monthly continuous), 3.59% (quarterly continuous), 3.18% (minimum discount strategy)[58] - Maximum Drawdown: -4.22% (monthly continuous), -3.75% (quarterly continuous), -3.91% (minimum discount strategy)[58] - Net Value: 1.0337 (monthly continuous), 1.0613 (quarterly continuous), 1.0529 (minimum discount strategy)[58] - Annual Turnover: 12 (monthly continuous), 4 (quarterly continuous), 16.15 (minimum discount strategy)[58] - 2025 YTD Return: 0.29% (monthly continuous), 1.19% (quarterly continuous), 1.17% (minimum discount strategy)[58] - **IM Hedging Strategy**: - Annualized Return: -5.86% (monthly continuous), -4.16% (quarterly continuous), -3.46% (minimum discount strategy)[60] - Volatility: 4.75% (monthly continuous), 5.80% (quarterly continuous), 5.61% (minimum discount strategy)[60] - Maximum Drawdown: -14.00% (monthly continuous), -12.63% (quarterly continuous), -11.11% (minimum discount strategy)[60] - Net Value: 0.8528 (monthly continuous), 0.8839 (quarterly continuous), 0.9006 (minimum discount strategy)[60] - Annual Turnover: 12 (monthly continuous), 4 (quarterly continuous), 16.02 (minimum discount strategy)[60] - 2025 YTD Return: -7.89% (monthly continuous), -2.89% (quarterly continuous), -1.81% (minimum discount strategy)[60] Quantitative Factors and Construction Methods Factor Name: Cinda-VIX - **Factor Construction Idea**: Reflects the market's expectation of future volatility of the underlying asset, with a term structure to reflect expectations over different periods[63] - **Factor Construction Process**: - **Algorithm Basis**: Based on the methodology discussed in the Cinda Derivatives Research Report Series IV[63] - **Current Values**: As of June 6, 2025, the 30-day VIX values for SSE 50, CSI 300, CSI 500, and CSI 1000 are 17.19, 16.45, 22.33, and 22.89, respectively[63] Factor Name: Cinda-SKEW - **Factor Construction Idea**: Measures the skewness of implied volatility (IV) of options with different strike prices, indicating market expectations of extreme events[68] - **Factor Construction Process**: - **Algorithm Basis**: Captures the skewness in IV to reflect market expectations of future returns distribution[68] - **Current Values**: As of June 6, 2025, the SKEW values for SSE

Core Viewpoint - Nanwei Technology is positioned as a leading company in high-performance nano microsphere materials, with significant improvements in performance margins and growth opportunities in the chromatography filler sector due to import substitution and commercialization expansion [2][3][6]. Company Overview - Established in 2007, Nanwei Technology specializes in the R&D, mass production, sales, and application services of high-performance nano microsphere materials for various sectors including biomedicine and diagnostics [2]. - The company faced growth pressures in 2023 due to external macroeconomic changes, but has shown significant performance recovery since Q4 2024, with a quarterly revenue of 233 million yuan, a year-on-year increase of 71.47%, and a net profit of 41 million yuan, up 38.05% [2]. Market Opportunities - The global chromatography media market is projected to grow from 6.9 billion USD in 2023 to 9 billion USD by 2026, with a compound annual growth rate (CAGR) of 9.26%. The Chinese market is expected to grow from 11.2 billion yuan to 20.3 billion yuan in the same period, with a CAGR of 21.92% [3]. - Nanwei Technology is well-positioned to benefit from two major opportunities: import substitution and commercialization expansion. The company has developed a comprehensive range of chromatography fillers and media, making it a key player in the domestic market [3][4]. Import Substitution Opportunity - The chromatography filler and media industry has been historically dominated by foreign companies, with low domestic production rates. The rapid development of the domestic biomedicine industry and geopolitical tensions are driving the need for local alternatives [3]. - Successful project changes by downstream client Heng Rui Pharmaceutical provide a template for future import substitution projects, positioning Nanwei Technology as a leader in this transition [3]. Commercialization Expansion Opportunity - The usage of chromatography fillers and media increases with project phases, from early clinical trials to commercialization. Nanwei Technology has accumulated a growing number of clients and is nurturing numerous mid-to-late clinical projects, which are expected to yield significant returns [4]. Industry Chain Layout - Beyond its core business, Nanwei Technology is expanding its industry chain through a combination of self-built and acquired entities, including subsidiaries focused on chromatography instruments and diagnostic materials [5]. - Key subsidiaries include: - Fuli Instruments, a leader in domestic chromatography instruments, has made strides in gas and liquid chromatography [5]. - NAP Analysis, which focuses on high-quality laboratory chromatography consumables, achieving full domestic production [5]. - Saip Instrument, which develops precision purification equipment for large biomolecules, establishing itself as a leader in the domestic market [5]. Financial Forecast - Revenue projections for Nanwei Technology are 1 billion yuan in 2025, 1.24 billion yuan in 2026, and 1.55 billion yuan in 2027, with corresponding net profits of 141 million yuan, 221 million yuan, and 285 million yuan [6]. - The company is expected to maintain a strong growth trajectory, supported by its leadership in the chromatography filler and media sector and its strategic industry chain expansions [6].

Core Viewpoint - Central Huijin has officially become the actual controller of eight companies, holding seven brokerage licenses, which strengthens its position in the financial sector and raises expectations for potential consolidation among brokerages [1][6]. Group 1: Central Huijin's Control and Licenses - The China Securities Regulatory Commission (CSRC) has approved Central Huijin to become the actual controller of eight companies, including Changcheng Guorui Securities and Dongxing Securities [1][2]. - With the addition of these eight companies, Central Huijin now controls a total of seven brokerage licenses, including those of Galaxy Securities, China International Capital Corporation (CICC), and others [1][5]. Group 2: Financial Asset Management Companies (AMCs) - In February, the Ministry of Finance transferred the equity of three major AMCs—China Cinda, China Great Wall, and China Orient—to Central Huijin, making it the controlling shareholder of these companies [1][5]. - This transfer aims to enhance the risk management capabilities of state-owned financial institutions as part of national institutional reforms [1][5]. Group 3: Financial Performance and Market Position - As of 2024, the total assets of major brokerages under Central Huijin include Galaxy Securities at 737.47 billion, Shenyin Wanguo at 697.60 billion, and CICC at 674.72 billion, among others, with the total asset scale of the brokerage sector approaching 3.2 trillion [5][6]. - The combined net profit of the seven brokerages reached 34.18 billion, with Galaxy Securities contributing 10.13 billion and CICC 7.22 billion, indicating a strong financial performance [6]. - Central Huijin's scale and profitability position it as a dominant player in the brokerage industry, with total assets nearly double that of CITIC Securities and net profits 1.6 times higher [6]. Group 4: Market Expectations for Consolidation - The increase in brokerage licenses under Central Huijin has heightened market expectations for potential mergers among brokerages, including speculation about mergers involving CICC, Galaxy Securities, and several AMC-affiliated brokerages [6].

中华人民共和国财政部（以下简称财政部）拟将其所持有的中国信达资产管 理股份有限公司（以下简称中国信达）的股权全部划转至中央汇金投资有限责任 公司（以下简称汇金公司），国家金融监督管理总局已正式批准中国信达本次股 权变更。具体内容详见信达证券股份有限公司（以下简称公司）于2025年5月9 日披露的《信达证券股份有限公司关于控股股东股权结构变更进展情况的公告》 （2025-010）。 近日，公司取得中国证券监督管理委员会批复（证监许可〔2025〕1175号）， 核准汇金公司成为公司实际控制人。本次划转完成后，公司控股股东仍为中国信 达，实际控制人将由财政部变更为汇金公司。 证券代码：601059 证券简称：信达证券 公告编号：2025-016 信达证券股份有限公司 关于实际控制人变更获得中国证监会核准的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 公司将持续关注该事项的进展，并按照相关法律法规的规定，及时履行信息 披露义务，敬请广大投资者理性投资，注意投资风险。 特此公告。 信达证券股份有限公司董事会 2025 年 6 月 ...

中央汇金的最新动作引发关注。 6月6日，据证监会网站，长城国瑞证券有限公司、东兴证券股份有限公司、信达证券股份有限公司、东兴基金管理有限公 司、信达澳亚基金管理有限公司、长城期货股份有限公司、东兴期货有限责任公司、信达期货有限公司的变更实际控制人申 请文件已获核准，中央汇金投资有限责任公司（以下简称"中央汇金公司"）成为其实际控制人。相关公司需按规定及时办理 工商变更登记等事宜，完善公司治理结构，维护公司及投资者合法权益。 中信证券认为，"汇金系"券商的股权调整有望推动证券行业新一轮并购，可关注证券行业同一实控人下行政化并购与市场化 并购主线，重点关注两方面，一是同属同一实控人的证券机构，二是后续市场化并购可能性较高的证券公司。 从行业动态来看，自去年以来，在监管鼓励券商通过并购重组做大做强等政策推动下，新一轮券商并购整合步伐加快，多个 并购组合取得实质性进展。 业内人士分析，未来券商并购重组将主要围绕"头部券商强强联合，整合资源优势做优做强"以及"中小券商结合股东背景、区 域优势等资源禀赋和专业能力做精做细，实现特色化、差异化发展"两个方向推进。 从实现路径上，同一实控人旗下的两家或多家券商、非金控类央企剥 ...

智通财经6月6日电，证监会核准中央汇金投资有限责任公司成为长城国瑞证券有限公司、东兴证券股份 有限公司、信达证券股份有限公司、东兴基金管理有限公司、信达澳亚基金管理有限公司、长城期货股 份有限公司、东兴期货有限责任公司、信达期货有限公司实际控制人。 ...

Group 1 - The core point of the announcement is that Manulife Investment Management Co., Ltd. has decided to participate in a fee discount activity for certain funds through Cinda Securities starting from June 6, 2025 [1][2]. - The fee discount applies to the purchase (including regular investment purchases) of designated funds sold by Manulife through Cinda Securities [2][3]. - The specific fee discount details will be based on information provided by Cinda Securities, and the original purchase fee will apply if it is a fixed fee [2][3]. Group 2 - The fee discount is only applicable to the handling fees for purchase transactions through Cinda Securities, excluding fees for subscription, redemption, and conversion of funds [3]. - During the fee discount period, if new funds are added for sale through Cinda Securities, the discount will also apply to those funds from the date of their sale [2][3]. - Investors can obtain further information or inquiries through Cinda Securities or Manulife Investment Management's customer service [4].

Market Outlook - A-shares are expected to experience a structural market in June, with a focus on core assets despite short-term downward pressure [1][2] - Institutions suggest maintaining dividend assets as a base while exploring growth and consumption opportunities, particularly in banking, computing industry chain, card games, and innovative pharmaceuticals [1][5] Market Performance Review - In May, the three major indices saw gains, with the Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index rising by 2.09%, 1.42%, and 2.32% respectively [1] - Daily trading volume in A-shares remained above 1 trillion yuan [1] Economic and Policy Factors - Economic recovery and positive domestic policies are expected to enhance market risk appetite, leading to a potential upward trend in June [2] - The stability of the Chinese economy and policy expectations may continue to favor Chinese assets, even amid global uncertainties [2] Sector Performance - In May, 25 out of 31 Shenwan first-level industries saw gains, with environmental protection, pharmaceuticals, defense, and banking leading the way [3] - There is a divergence among institutions regarding market style and focus for June, with some favoring technology growth while others lean towards large-cap value stocks [3][4] Investment Strategies - Suggested strategies include focusing on technology growth sectors, consumer sectors benefiting from domestic policies, and banking sectors with stable earnings and high dividends [5][6] - Specific recommendations include investing in robotics, artificial intelligence, and sectors with recent thematic catalysts, such as innovative pharmaceuticals and military electronics [5][6]

每经记者｜王砚丹 每经编辑｜彭水萍 上市券商2024年度权益分派还未结束，而2025年年中分红方面，投资者又迎来了好消息。 5月29日晚间，信达证券发布公告称，公司董事会审议通过《关于2025年度中期现金分红有关事项的议 案》，在具备中期现金分红条件的情况下，公司拟以2025年年初至该中期期末实现的未经审计的归属于 母公司股东净利润为基础，按不超过15%的比例进行2025年度中期现金分红。 值得一提的是，2024年全年有超过30家券商进行了2次或多次分红。多家上市券商也表态将择机向投资 者增加分红频率。虽然距离2025年中期报告为时尚早，但在2025年以来券商业绩稳健增长的背景下，投 资者有很大概率收到中期红包。 回报投资者，券商积极策划中期分红 其实，信达证券并不是首家明确将要在2025年中期进行现金分红的券商。5月28日，华鑫证券的母公司 华鑫股份发布了即将提交2024年年度股东大会审核的材料。在年度股东大会中，华鑫股份不仅要审核 2024年度利润分配议案，也要同时审议关于2025年度中期分红安排。 公告显示，华鑫股份2024年年度分红方案为：按每10股派送现金红利0.78元（含税）。 而2025年中期分 ...